
Corteva Inc (CTVA) Stock Forecast & Price Target
Corteva Inc (CTVA) Analyst Ratings
Bulls say
Corteva's management has reaffirmed its 2025 financial guidance and expressed comfort with the current consensus for 2026, indicating confidence in future performance. The company is projected to generate revenues of approximately $3,845 million, which is slightly above the consensus estimate of $3,823 million. Notably, Corteva's sum-of-the-parts valuation suggests a potential 12% upside over the next 12 months, with shares currently trading at 12.0x estimated EV/EBITDA for 2025, reinforcing a positive outlook for the stock.
Bears say
Corteva’s upcoming spin-off of its seeds business in 2026 is anticipated to lead to reduced growth and margin expectations in its crop protection segment, which may negatively impact the financial outlook for the company. Risks such as potential declines in crop prices due to oversupply, growing competition from Bayer, and advancements in precision application technology further exacerbate uncertainties facing Corteva's operational performance. Additionally, the company's stock may experience stagnation during what has been termed "deal purgatory" until the execution of the spin-off.
This aggregate rating is based on analysts' research of Corteva Inc and is not a guaranteed prediction by Public.com or investment advice.
Corteva Inc (CTVA) Analyst Forecast & Price Prediction
Start investing in Corteva Inc (CTVA)
Order type
Buy in
Order amount
Est. shares
0 shares